Curanex Pharmaceuticals, Inc. (CURX)
4.410
-0.03
(-0.67%)
USD |
NASDAQ |
Nov 20, 16:00
4.44
+0.03
(+0.67%)
After-Hours: 20:00
Curanex Pharmaceuticals Total Liabilities (Quarterly) : 0.5518M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.5518M |
| June 30, 2026 | 0.2863M |
| March 31, 2026 | 0.3326M |
| December 31, 2025 | 0.361M |
| September 30, 2025 | 0.186M |
| June 30, 2025 | 0.4817M |
| Date | Value |
|---|---|
| March 31, 2025 | 0.4212M |
| December 31, 2024 | 0.0146M |
| September 30, 2024 | 0.0056M |
| June 30, 2024 | 0.0006M |
| March 31, 2024 | |
| December 31, 2023 | 0.0143M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Breakthrough Chemistry, Inc. | 0.4599M |
| Kaya Holdings, Inc. | 2.920M |
| Cardiac Biotech Solutions, Inc. | 2.771M |
| Endexx Corp. | -- |
| Earth Science Tech, Inc. | 2.783M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.097M |
| Shareholders Equity (Quarterly) | 2.545M |
| Debt to Equity Ratio | 0.213 |
| Current Ratio | 17.84 |
| Net Debt Paydown Yield | -0.17% |